Literature DB >> 34532717

Colorectal Cancer Screening and Prevention in the COVID-19 Era.

Rachel B Issaka1,2, Ma Somsouk3,4.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 34532717      PMCID： PMC8443218          DOI： 10.1001/jamahealthforum.2020.0588

Source DB:  PubMed          Journal:  JAMA Health Forum        ISSN： 2689-0186


× No keyword cloud information.
  7 in total

Review 1.  Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis.

Authors:  Jeffrey K Lee; Elizabeth G Liles; Stephen Bent; Theodore R Levin; Douglas A Corley
Journal:  Ann Intern Med       Date:  2014-02-04       Impact factor: 25.391

Review 2.  Screening for Colorectal Neoplasia.

Authors:  John M Inadomi
Journal:  N Engl J Med       Date:  2017-01-12       Impact factor: 91.245

3.  Effectiveness and Cost of Organized Outreach for Colorectal Cancer Screening: A Randomized, Controlled Trial.

Authors:  Ma Somsouk; Carly Rachocki; Ajitha Mannalithara; Dianne Garcia; Victoria Laleau; Barbara Grimes; Rachel B Issaka; Ellen Chen; Eric Vittinghoff; Jean A Shapiro; Uri Ladabaum
Journal:  J Natl Cancer Inst       Date:  2020-03-01       Impact factor: 13.506

4.  International Perspective on the Burden of Colorectal Cancer and Public Health Effects.

Authors:  Linda Rabeneck; Han-Mo Chiu; Carlo Senore
Journal:  Gastroenterology       Date:  2019-10-14       Impact factor: 22.682

5.  Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.

Authors: 
Journal:  Lancet       Date:  2016-10-08       Impact factor: 79.321

6.  Mailed fecal immunochemical test outreach for colorectal cancer screening: Summary of a Centers for Disease Control and Prevention-sponsored Summit.

Authors:  Samir Gupta; Gloria D Coronado; Keith Argenbright; Alison T Brenner; Sheila F Castañeda; Jason A Dominitz; Beverly Green; Rachel B Issaka; Theodore R Levin; Daniel S Reuland; Lisa C Richardson; Douglas J Robertson; Amit G Singal; Michael Pignone
Journal:  CA Cancer J Clin       Date:  2020-06-25       Impact factor: 286.130

7.  Standardized Workflows Improve Colonoscopy Follow-Up After Abnormal Fecal Immunochemical Tests in a Safety-Net System.

Authors:  Rachel B Issaka; Carly Rachocki; Michael P Huynh; Ellen Chen; Ma Somsouk
Journal:  Dig Dis Sci       Date:  2020-03-31       Impact factor: 3.199
  7 in total
  16 in total

1.  Clinic Factors Associated With Mailed Fecal Immunochemical Test (FIT) Completion: The Difference-Making Role of Support Staff.

Authors:  Melinda M Davis; Jennifer L Schneider; Amanda F Petrik; Edward J Miech; Brittany Younger; Anne L Escaron; Jennifer S Rivelli; Jamie H Thompson; Denis Nyongesa; Gloria D Coronado
Journal:  Ann Fam Med       Date:  2022 Mar-Apr       Impact factor: 5.166

2.  Recovery of cancer screening tests and possible associated disparities after the first peak of the COVID-19 pandemic.

Authors:  Chris Labaki; Ziad Bakouny; Andrew Schmidt; Stuart R Lipsitz; Timothy R Rebbeck; Quoc-Dien Trinh; Toni K Choueiri
Journal:  Cancer Cell       Date:  2021-07-01       Impact factor: 38.585

3.  Source matters: a survey of cost variation for fecal immunochemical tests in primary care.

Authors:  Jennifer Coury; Katrina Ramsey; Rose Gunn; Jon Judkins; Melinda Davis
Journal:  BMC Health Serv Res       Date:  2022-02-15       Impact factor: 2.655

Review 4.  From Cancer Epidemiology to Policy and Practice: the Role of a Comprehensive Cancer Center.

Authors:  Robert A Hiatt; Amanda Sibley; Brinda Venkatesh; Joyce Cheng; Niharika Dixit; Rena Fox; Pamela Ling; Tung Nguyen; Debora Oh; Nynikka R Palmer; Rena J Pasick; Michael B Potter; Ma Somsouk; Roberto Ariel Vargas; Maya Vijayaraghavan; Alan Ashworth
Journal:  Curr Epidemiol Rep       Date:  2022-03-21

5.  Predictors of Colorectal Cancer Screening Modality Among Newly Age-Eligible Medicaid Enrollees.

Authors:  Cynthia M Mojica; Bonnie Lind; Yifan Gu; Gloria D Coronado; Melinda M Davis
Journal:  Am J Prev Med       Date:  2020-11-19       Impact factor: 5.043

6.  Risk of missing colorectal cancer with a COVID-adapted diagnostic pathway using quantitative faecal immunochemical testing.

Authors:  Y Maeda; E Gray; J D Figueroa; P S Hall; D Weller; M G Dunlop; F V N Din
Journal:  BJS Open       Date:  2021-07-06

7.  Impact of the COVID-19 Pandemic on Utilization of EGD and Colonoscopy in the United States: An Analysis of the GIQuIC Registry.

Authors:  Audrey H Calderwood; Michael S Calderwood; J Lucas Williams; Jason A Dominitz
Journal:  Tech Innov Gastrointest Endosc       Date:  2021-07-30

Review 8.  COVID-19 and the other pandemic: populations made vulnerable by systemic inequity.

Authors:  Darrell M Gray; Adjoa Anyane-Yeboa; Sophie Balzora; Rachel B Issaka; Folasade P May
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-09       Impact factor: 73.082

9.  The impact of the coronavirus disease 2019 pandemic on the diagnosis and treatment of cancer in Northern Portugal.

Authors:  Samantha Morais; Luís Antunes; Jéssica Rodrigues; Filipa Fontes; Maria José Bento; Nuno Lunet
Journal:  Eur J Cancer Prev       Date:  2022-03-01       Impact factor: 2.497

10.  Program Components and Results From an Organized Colorectal Cancer Screening Program Using Annual Fecal Immunochemical Testing.

Authors:  Kevin Selby; Christopher D Jensen; Theodore R Levin; Jeffrey K Lee; Joanne E Schottinger; Wei K Zhao; Douglas A Corley; Chyke A Doubeni
Journal:  Clin Gastroenterol Hepatol       Date:  2020-09-30       Impact factor: 13.576
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.